In a breakthrough that could reshape the future of cancer care, Nanocrine—a Maryland-based biotech startup—has unveiled its RT-Chip™ technology, a next-generation biosensor platform that enables real time observation of tumor activity at the cellular level...

Researchers are unveiling a breakthrough lab technique that advances the new age of personalized cancer care. Nanocrine says its RT-Chip™ for live cell imaging for the first time enables scientists the ability to visualize cell-to-cell signaling as it is occurring in a malignant tumor and other disease microenvironments. The research is scheduled to be formally presented at the...

Researchers are unveiling a breakthrough lab technique that advances the new age of personalized cancer care. Nanocrine says its RT-Chip™ for live cell imaging for the first time enables scientists the ability to visualize cell-to-cell signaling as it is occurring in a malignant tumor and other disease microenvironments. The research is scheduled to be formally presented at the...

Preview of breakthrough research to be formally unveiled at the Dec. 6th CELL BIO2025 Meeting of American Society of Cell Biologists, Philadelphia. Nanocrine’s revolutionary RT Chip™ for plasmonic live cell imaging for the first time enables scientists the ability to visualize cell-to-cell signaling as it is occurring in time and space, for single cells or tissue architectures...